RON BENTSUR - 20 Jul 2023 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role: Chairman & CEO, Director, 10%+ Owner
Signature: /s/ Ron Bentsur
Issuer symbol: NVCT
Transactions as of: 20 Jul 2023
Net transactions value: +$4,998
Form type: 4
Filing time: 24 Jul 2023, 16:45:52 UTC
Previous filing: 20 Jul 2023
Next filing: 11 Aug 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCT	Common Stock	Purchase	$1,657	+110	+0%	$15.06	3,231,669	20 Jul 2023	Direct	F1
transaction	NVCT	Common Stock	Purchase	$3,341	+225	+0.01%	$14.85	3,231,894	21 Jul 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 426,759 shares of restricted stock.
F2	Reflects the weighted average purchase price. The range of prices for the shares purchased was $14.55 to $15.14. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.

Content

Includes 426,759 shares of restricted stock.

Reflects the weighted average purchase price. The range of prices for the shares purchased was $14.55 to $15.14. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.